Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
10.68
-0.31 (-2.82%)
Nov 20, 2024, 4:00 PM EST - Market closed
Atara Biotherapeutics Employees
Atara Biotherapeutics had 225 employees as of December 31, 2023. The number of employees decreased by 109 or -32.63% compared to the previous year.
Employees
225
Change (1Y)
-109
Growth (1Y)
-32.63%
Revenue / Employee
$446,396
Profits / Employee
-$591,822
Market Cap
60.60M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
InterCure | 270 |
Metagenomi | 236 |
Champions Oncology | 210 |
Exagen | 179 |
Hyperfine | 131 |
VolitionRx | 110 |
X4 Pharmaceuticals | 93 |
Spero Therapeutics | 46 |
ATRA News
- 7 days ago - Atara Biotherapeutics to Participate at the Stifel 2024 Healthcare Conference - Business Wire
- 8 days ago - Atara Biotherapeutics Announces Third Quarter 2024 Financial Results and Operational Progress - Business Wire
- 15 days ago - Atara Biotherapeutics to Announce Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - Business Wire
- 6 weeks ago - Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Atara Biotherapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - Business Wire
- 2 months ago - Atara Biotherapeutics Announces $36 Million Registered Direct Offering - Business Wire
- 3 months ago - Atara Biotherapeutics Announces Second Quarter 2024 Financial Results, Operational Progress and Leadership Update - Business Wire
- 3 months ago - Atara Biotherapeutics to Participate in the Canaccord Genuity 44th Annual Growth Conference - Business Wire